Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.
Publication
, Journal Article
DeFilipp, Z; Purcell, M; Harris, WAC; Chandra, DJ; Gleason, C; Wrammert, J; Sarantopoulos, S; Waller, EK
Published in: Bone Marrow Transplant
April 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Bone Marrow Transplant
DOI
EISSN
1476-5365
Publication Date
April 2016
Volume
51
Issue
4
Start / End Page
607 / 609
Location
England
Related Subject Headings
- Rituximab
- Peripheral Blood Stem Cell Transplantation
- Monitoring, Physiologic
- Leukemia, Myeloid, Acute
- Immunology
- Humans
- Graft vs Host Disease
- Female
- Breast Neoplasms
- B-Lymphocytes
Citation
APA
Chicago
ICMJE
MLA
NLM
DeFilipp, Z., Purcell, M., Harris, W. A. C., Chandra, D. J., Gleason, C., Wrammert, J., … Waller, E. K. (2016). Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. Bone Marrow Transplant, 51(4), 607–609. https://doi.org/10.1038/bmt.2015.304
DeFilipp, Z., M. Purcell, W. A. C. Harris, D. J. Chandra, C. Gleason, J. Wrammert, S. Sarantopoulos, and E. K. Waller. “Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.” Bone Marrow Transplant 51, no. 4 (April 2016): 607–9. https://doi.org/10.1038/bmt.2015.304.
DeFilipp Z, Purcell M, Harris WAC, Chandra DJ, Gleason C, Wrammert J, et al. Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. Bone Marrow Transplant. 2016 Apr;51(4):607–9.
DeFilipp, Z., et al. “Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.” Bone Marrow Transplant, vol. 51, no. 4, Apr. 2016, pp. 607–09. Pubmed, doi:10.1038/bmt.2015.304.
DeFilipp Z, Purcell M, Harris WAC, Chandra DJ, Gleason C, Wrammert J, Sarantopoulos S, Waller EK. Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD. Bone Marrow Transplant. 2016 Apr;51(4):607–609.
Published In
Bone Marrow Transplant
DOI
EISSN
1476-5365
Publication Date
April 2016
Volume
51
Issue
4
Start / End Page
607 / 609
Location
England
Related Subject Headings
- Rituximab
- Peripheral Blood Stem Cell Transplantation
- Monitoring, Physiologic
- Leukemia, Myeloid, Acute
- Immunology
- Humans
- Graft vs Host Disease
- Female
- Breast Neoplasms
- B-Lymphocytes